SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Effective at the Annual Meeting, the audit committee was reconstituted with Blane Walter as Chair and Edward M. Straw and Michel Lee as members. This governance change affects the registrant's control environment and audit oversight.
View raw filing on EDGAR →McEwen Inc. received a $49.4 million dividend from its 46.3% ownership stake in McEwen Copper Inc., bringing 2026 total dividends to $58.2 million from the San José mine operations. While this represents a significant cash inflow and is material to investors assessing the company's financial position and cash generation, it does not fit neatly into the more specific event categories (not an earnings release, M&A activity, impairment, or other defined event types). The disclosure is material because it affects the total mix of information about the registrant's financial performance and liquidity.
View raw filing on EDGAR →Stockholders approved material amendments to the Certificate of Incorporation: doubling authorized common shares from 283.8M to 567.5M and eliminating Series A and Series B Preferred Stock designations, representing a significant capital structure change.
View raw filing on EDGAR →The disclosure announces presentation of translational data from clinical studies (GOBLET and AWARE-1) at a major medical conference (ASCO Annual Meeting), describing pelareorep's mechanism of action and immune system effects. While this represents material clinical/scientific progress for a biotech company, it does not fit neatly into more specific event categories (not an earnings release, not a regulatory approval, not a material impairment or litigation). The announcement of clinical data presentation at a major conference would be material to investors assessing the company's pipeline and therapeutic potential.
View raw filing on EDGAR →The Board approved and the company announced a 1-for-8 reverse stock split of SCYNEXIS common stock, effective May 29, 2026, which was previously authorized by stockholders and affects share structure, authorized shares, and trading mechanics.
View raw filing on EDGAR →The filing discloses interim clinical trial results being presented at a major oncology conference (ASCO 2026). While this could represent material clinical progress for a therapeutics company, the Item 8.01 disclosure lacks sufficient detail to confirm whether these results constitute a formal earnings release, material impairment, or other specific event type. The announcement of interim trial data at a scientific conference is material to investors but does not fit cleanly into the more specific taxonomy categories.
View raw filing on EDGAR →The company adopted bylaw amendments in connection with a pending merger with Ligand Pharmaceuticals, including provisions related to Nevada controlling interest statutes and exclusive forum selection that affect shareholder rights and dispute resolution procedures.
View raw filing on EDGAR →Assembly Biosciences announced a material expansion of its lead clinical candidate ABI-6250 from HDV infection into two additional cholestatic liver disease indications (PBC and PSC), with Phase 2 trials planned for Q4 2026 and Q1 2027, supported by preclinical data and constructive FDA pre-IND meeting feedback.
View raw filing on EDGAR →The filing discloses a revised, unsolicited acquisition proposal from Bradley L. Radoff, Michael Torok, and affiliates received on May 14, 2026. While this involves potential M&A activity, the proposal is explicitly characterized as "highly contingent, non-binding and unsolicited," which distinguishes it from a definitive agreement or binding transaction. The disclosure is material to investors as it signals potential change-of-control activity, but the contingent and non-binding nature prevents classification as a completed or definitive ma_activity event.
View raw filing on EDGAR →The Index Provider announced on May 19, 2026, a change to the Constituent Trading Platforms used to calculate the Index Price for the Fund's components (Bitcoin, Ether, SOL, and BNB). The addition of OSL, Bybit, and Gemini as trading venues affects how the Fund values its holdings and calculates net asset value. While this is an operational/methodological change rather than a discrete event like M&A, restatement, or litigation, it is material to investors because it directly impacts the pricing mechanism and valuation of the Fund's assets.
View raw filing on EDGAR →The filing discloses a prospectus for approximately $1.27 billion in aggregate principal amount of asset-backed notes issued by Nissan Auto Receivables 2026-A Owner Trust, structured across seven classes. While this represents a material securitization transaction, it does not fit cleanly into the standard M&A or dilutive issuance categories—it is a structured finance offering of asset-backed securities backed by an auto receivables pool. This is material to investors but best classified as other_material given the specialized securitization structure.
View raw filing on EDGAR →Byline Bancorp entered into the Third Amendment to its credit agreement with CIBC Bank USA on May 22, 2026, renewing a $15 million revolving line of credit and extending the maturity date to May 23, 2027. This is a routine renewal and extension of an existing credit facility that confirms continued access to liquidity.
View raw filing on EDGAR →This Item 8.01 disclosure announces May 2026 distributions ($0.165 gross per share across three share classes), reports NAV per share of $26.36 as of April 30, 2026, and provides an update on the Fund's continuous offering status and capital raised ($553.2 million total consideration across registered and private placements). While distribution declarations and NAV reporting are routine for closed-end funds, the combination of distribution amounts, NAV, leverage metrics (0.89x debt-to-equity), and offering progress would be material to investors assessing the Fund's income generation and capital structure. However, this does not fit neatly into the more specific event categories (not an earnings release, M&A, impairment, or executive change), so "other_material" is most appropriate.
View raw filing on EDGAR →The Board of Directors authorized a renewal and increase of the company's stock repurchase program to $1.5 billion, representing a material capital allocation decision that affects shareholder value and the company's financial strategy.
View raw filing on EDGAR →Americold entered into a Fourth Amendment to its Credit Agreement on May 18, 2026, extending the maturity date of a $250 million Delayed Draw Term Facility from June 19, 2026 to September 19, 2026. This debt facility extension is material to investors assessing the company's liquidity and refinancing risk.
View raw filing on EDGAR →The Company terminated a material definitive agreement with CEO Karl G. Glassman regarding aircraft time-sharing for personal use and announced the planned sale of company aircraft, representing a material change in executive perquisites and company asset strategy.
View raw filing on EDGAR →Generation Income Properties entered into a $3.8 million Commercial Business Loan Agreement with Hancock Whitney Bank to refinance existing mortgage indebtedness on two properties, creating a direct financial obligation.
View raw filing on EDGAR →This 8-K Item 8.01 discloses a material amendment to the Company's proxy statement regarding an extension of the business combination deadline from 18 months to 27 months from IPO, contingent on sponsor funding of up to $60,000 per monthly extension. While this is a shareholder vote matter, it does not fit neatly into "shareholder_vote_results" (which reports outcomes of votes already held) but rather announces a material modification to terms being submitted for shareholder approval at the June 18, 2026 Extraordinary General Meeting. The extension materially affects the timeline and economics of the SPAC's business combination obligation and redemption rights, making it material to investors.
View raw filing on EDGAR →Akamai used approximately $350 million of net proceeds from the convertible notes offering to repurchase 2.48 million shares of common stock at $141.34 per share in privately negotiated transactions, representing a material capital allocation decision concurrent with the debt offering.
View raw filing on EDGAR →The company announced multiple material corporate developments: commencement of Nasdaq trading under ticker 'EMAT,' a $100 million convertible debenture facility with YA II PN, Ltd., and binding purchase orders for thirteen rare earth magnet production machines. These developments reflect significant operational progress, capital raising, and strategic expansion initiatives.
View raw filing on EDGAR →LQR House Inc. entered into a Note Purchase Agreement on May 20, 2026, issuing unsecured promissory notes with an aggregate principal amount of up to $60,000,000 to non-U.S. purchasers. The notes may be convertible or involve digital asset funding, creating a material direct financial obligation.
View raw filing on EDGAR →This disclosure reports completion of an IPO of 15,000,000 units at $10.00 per unit, a concurrent private placement of 2,750,000 warrants, and partial exercise of an over-allotment option, resulting in total trust account proceeds of $157,785,000 as of May 20, 2026. While the IPO itself is a material capital-raising event, the disclosure is structured as a narrative of completed transactions rather than a traditional earnings release or M&A activity, and does not fit cleanly into the earnings_release or ma_activity categories; it is best classified as other_material given its significance to a blank-check acquisition vehicle's capitalization and timeline for business combination.
View raw filing on EDGAR →This disclosure reports the consummation of Patriot Acquisition Corp.'s IPO on May 18, 2026, generating $160 million in gross proceeds from 16 million units, plus a concurrent private placement of 5.2 million warrants and subsequent partial exercise of the over-allotment option adding $15.075 million, resulting in $175.875 million in trust. While the IPO itself is a material capital-raising event, it does not fit cleanly into the earnings_release category (which typically applies to periodic financial results) or dilutive_issuance (which focuses on unregistered equity sales to raise cash in distressed contexts). This is a SPAC formation event—material to investors but best classified as other_material given the specialized nature of blank-check company capitalization.
View raw filing on EDGAR →The disclosure announces that unit holders may elect to separately trade the component securities (Class A ordinary shares, Warrants, and Rights) of the Company's IPO units, commencing May 28, 2026, with new trading symbols assigned to each component. While this is a routine post-IPO administrative event for a SPAC, it is material to investors as it affects the liquidity and trading mechanics of their securities and represents a significant milestone in the Company's capital structure. This does not fit neatly into more specific categories (not an earnings release, executive change, M&A, impairment, or covenant breach), making "other_material" the appropriate classification.
View raw filing on EDGAR →The filing discloses a shareholder letter for Q1 2026 under Item 7.01 (Regulation FD Disclosure). While the letter likely contains financial or operational updates material to investors, the 8-K itself does not specify the content—only that a letter was issued. Without access to Exhibit 99.1, the precise event type cannot be determined; it could relate to earnings, business developments, or other material matters. Classified as other_material given the uncertainty about the letter's specific content, though it is material enough to warrant 8-K disclosure.
View raw filing on EDGAR →This disclosure reports the consummation of a SPAC initial public offering on May 18, 2026, generating $150 million in gross proceeds from the sale of 15 million units at $10.00 per unit, plus a concurrent private placement of $5.375 million. While the IPO itself is a material capital-raising event affecting the registrant's financial position and shareholder base, it does not fit cleanly into the standard 8-K taxonomy categories (not an earnings release, M&A activity, or other specifically enumerated event types). The disclosure is material to investors as it documents the company's capitalization and trust account structure, but the event is primarily administrative/transactional in nature rather than a discrete material event like a covenant breach, impairment, or executive change.
View raw filing on EDGAR →Aperture AC amended its memorandum and articles of association in connection with the IPO, a material corporate governance event disclosed in the Registration Statement.
View raw filing on EDGAR →The Board adopted a stock repurchase program authorizing repurchases of up to 5% of common stock over the next twelve months. While share repurchases are material capital allocation decisions that affect shareholder value and earnings per share, this disclosure does not fit neatly into the more specific event categories (it is not an earnings release, M&A activity, executive change, impairment, or other defined event type). The announcement is material to investors as it signals management's confidence and capital deployment strategy, but lacks a dedicated taxonomy entry.
View raw filing on EDGAR →The disclosure announces acceptance of an abstract featuring pooled cardiac safety data for Annamycin (the company's lead drug candidate) for poster presentation at the 2026 ASCO Annual Meeting. For a clinical-stage biotech company, positive clinical data presentations at major medical conferences are material to investors assessing development progress and regulatory pathway viability. However, this does not fit neatly into the more specific event categories (it is not an earnings release, executive change, M&A activity, impairment, or litigation), so "other_material" is most appropriate.
View raw filing on EDGAR →The filing discloses two material definitive agreements entered into by the Fund: a Custodial Services Agreement with BitGo Bank & Trust for bitcoin safekeeping and a Master Purchase Agreement with BitGo Prime for bitcoin trading services. While these are operational agreements essential to the Fund's bitcoin holdings and trading activities, they do not constitute a traditional M&A transaction (acquisition, disposition, merger, or change of control). The agreements establish critical infrastructure for the Fund's operations but lack the transformative character typical of ma_activity events. This is best classified as other_material given the material nature of the agreements to the Fund's operations but their operational rather than transactional character.
View raw filing on EDGAR →The filing discloses that Cayson Acquisition Corp's insiders deposited a $125,000 contribution on May 21, 2026, as the third monthly installment required under a shareholder-approved extension of the business combination deadline to March 23, 2027. While this relates to a SPAC's extension mechanism and insider funding, it does not cleanly fit the standard taxonomy categories (not an M&A completion, not a shareholder vote result per se, not a covenant breach). The contribution to the trust account is material to investors assessing the company's runway and commitment to completing a business combination, but the event is primarily administrative in nature—a routine funding deposit under a previously approved extension plan.
View raw filing on EDGAR →The filing discloses Amendment No. 3 to the Fifth Amended and Restated Advisory Agreement between Braemar Hotels and its advisor Ashford Inc., extending the negotiation period for revised Base Fee and Incentive Fee terms through December 31, 2026. While this is a material definitive agreement amendment affecting the company's advisory fee structure, it does not fit cleanly into the more specific event categories (not M&A, not exec compensation, not a routine administrative change). The amendment's materiality lies in its potential impact on the company's operating costs and advisor relationship, warranting disclosure as a material event.
View raw filing on EDGAR →The Board approved a $150 million stock repurchase program on May 18, 2026, representing a material capital allocation decision affecting shareholder value and the company's financial flexibility.
View raw filing on EDGAR →Merck closed a $5.5 billion underwritten public offering of debt securities across seven tranches (Floating Rate Notes, 2028, 2031, 2033, 2036, 2046, and 2056 Notes). While this is a material financing event affecting the company's capital structure and liquidity, it does not fit neatly into the specific taxonomy categories (not M&A, not a dilutive equity issuance, not a restatement or covenant breach). This is a significant debt issuance that would materially affect a reasonable investor's assessment of the registrant's financial position and leverage.
View raw filing on EDGAR →The CEO's remarks disclose material information about the company's liquidity strategy and portfolio performance, including a decline in net asset value from $0.27 to $0.29 per share driven by Denver multifamily market softness, and acknowledgment that "uncertainty around the terms, timing, and completion risk for one material transaction in our non-core portfolio delayed our ability to deliver a liquidity event." While the disclosure centers on forward-looking plans for a potential liquidity event rather than a completed transaction or specific executive action, the material transaction delays and NAV decline would affect a reasonable investor's assessment of the REIT's near-term prospects and shareholder value realization.
View raw filing on EDGAR →iPower Inc. implemented a 1-for-8 reverse stock split of its common stock, approved by stockholders on December 21, 2025, and effective May 22, 2026. The reverse split affects share count, per-share metrics, and trading mechanics on Nasdaq, and was announced on May 19, 2026.
View raw filing on EDGAR →The disclosure announces topline results from a Phase 2b clinical trial (LUMA study) for BIIB122 (DNL151), a Parkinson's disease candidate co-developed with Biogen. While clinical trial results are material to investors evaluating the company's pipeline and prospects, this does not fit neatly into the standard taxonomy categories (not an earnings release, M&A activity, or other enumerated event types). The Regulation FD disclosure format and emphasis on trial outcomes support classification as a material event outside the specific categories.
View raw filing on EDGAR →Sadot Group Inc. approved and filed a 1-for-20 reverse stock split, effective May 27, 2026, explicitly intended to raise the per-share bid price above $1.00 to comply with Nasdaq Listing Rule 5550(a)(2) and address delisting risk. The amendment was disclosed via press release on May 22, 2026.
View raw filing on EDGAR →This 8-K discloses the completion of Berto Acquisition Corp. II's initial public offering (IPO) on May 18, 2026, raising $315.1 million in gross proceeds from the sale of 31.51 million units, plus a concurrent private placement of 3.5 million warrants for $3.5 million. While IPO completion is a material capital-raising event affecting the registrant's financial position and investor base, it does not fit neatly into the standard taxonomy categories (earnings_release, ma_activity, dilutive_issuance, etc.). The disclosure is material to investors as it establishes the company's public status and capital structure, but the event itself—an IPO completion—is best classified as other_material.
View raw filing on EDGAR →Disclosure of fund portfolio composition, NAV per share ($4,618 million), portfolio fair value ($9,994 million), leverage ratios (1.21x debt-to-equity), and ongoing public offering activity ($3.9+ billion in Class I shares issued) as of April 30, 2026.
View raw filing on EDGAR →This 8-K discloses routine monthly net asset value determinations, public offering price adjustments, and distribution declarations for CNL Strategic Capital, LLC—standard administrative disclosures for a closed-end fund. While the NAV, offering prices, and distributions are material to shareholders, they do not fit the specific event-type taxonomy (no earnings release, M&A, executive changes, impairments, covenant breaches, or other discrete triggering events). The filing is primarily informational rather than event-driven, making "other_material" the most appropriate classification.
View raw filing on EDGAR →CNL Strategic Residential Credit entered into a First Amendment to its Loan and Security Agreement with Valley National Bank on May 22, 2026, expanding the existing $15 million revolving line of credit by an additional $5 million to support liquidity covenant compliance under existing repurchase agreement facilities. The amendment reflects the Company's need to enhance financial flexibility and maintain covenant compliance.
View raw filing on EDGAR →Unum Group announced a Board-authorized increase in its quarterly dividend from an unstated prior rate to 50.5 cents per share ($2.02 annualized), effective Q3 2026. While dividend increases are material to shareholders and affect total shareholder return expectations, this disclosure does not fit neatly into the more specific event categories (it is not an earnings release, executive compensation arrangement, or shareholder vote result). The event is material to a reasonable investor but is best classified as other_material given the taxonomy's specificity.
View raw filing on EDGAR →EOG Resources' Board of Directors increased the company's share repurchase authorization from $10 billion to $20 billion effective May 20, 2026, adding $10 billion in repurchase capacity.
View raw filing on EDGAR →The company declared a quarterly cash dividend of $0.29 per share, representing a material capital allocation decision affecting shareholder returns.
View raw filing on EDGAR →The filing discloses updated risk factor disclosures in connection with the proposed Park Holidays transaction and Purchase Agreement, providing supplemental disclosure of risks associated with the material M&A activity.
View raw filing on EDGAR →The registrant announced a cash dividend declaration of $0.16 per common share. While dividend declarations are routine corporate actions, they are material to shareholders as they represent a direct return of capital and signal management's confidence in cash flow. However, this does not fit neatly into the more specific event categories (it is not an earnings release, executive change, M&A activity, or financial restatement), so "other_material" is the most appropriate classification.
View raw filing on EDGAR →SR Bancorp announced authorization of a third stock repurchase program for up to 10% of outstanding shares (801,320 shares). While share repurchases can signal management confidence and affect capital allocation, this disclosure does not fit neatly into the more specific event categories. The announcement is material to investors as it reflects corporate capital strategy, but lacks the specificity of a dilutive issuance or other defined event type.
View raw filing on EDGAR →The Board declared a cash distribution of $1.79 per share to shareholders, which is material to investors as it affects shareholder returns and cash flow.
View raw filing on EDGAR →Cognizant drew $1 billion under its revolving credit facility on May 20, 2026, creating a direct financial obligation under Item 2.03. While this is a material debt incurrence that would affect investor assessment of liquidity and leverage, it does not fit neatly into the more specific event categories (covenant_breach, going_concern, or dilutive_issuance). The filing discloses a routine credit facility draw rather than a breach, distress signal, or equity issuance, making "other_material" the most appropriate classification.
View raw filing on EDGAR →